Cornea

A unique case study of HZO featuring Steve Silberberg, OD, DipABO, as the patient.

Kramer, OD, FAAO, FSLS, presented alongside Kelsea Skidmore, OD, MS; Vivien Tse, OD; and Elaine Chen, OD, at this year's conference.

The PDUFA target action date is June 30, 2026.

Clark Chang, OD, MSA, MSc, FAAO; and Michelle Chung, OD, FAAO, FSLS, provided cornea updates during the American Academy of Optometry Academy 2025 conference.

NK is more common than recognized; early diagnosis is paramount.

The trial evaluated the safety, efficacy, and tolerability of AURN001 in patients with corneal edema secondary to corneal endothelial dysfunction.

The FDA-approved topical cross-linking treatment aims to simplify keratoconus care while improving patient comfort, with availability expected in early 2026.

The cross-linking system does not disrupt the epithelium, and does not require documentation of disease progression, according to a press release from Epion Therapeutics.

Allen discussed therapies such as perfluorohexyloctane and amniotic membrane use, stressing the importance of timely treatment and coordinated patient management.

The study compared visual, refractive, and patient-reported outcomes following implantation of enVista Envy and the enVista monofocal intraocular lens (IOL) in patients undergoing cataract surgery.

The trial will evaluate the solution in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

The lens portfolio includes spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry, and keratoconic contact lenses.

Calista Ming, OD, FAAO, FSLS, provides 3 cases of how to fit specialty lenses at the right time for patients.

The acquisition focuses on LayerBio's OcuRing-K technology, with plans to initiate the next clinical trial.

With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.

In a climate of shrinking reimbursements and rising costs, finding your niche isn’t just smart—it’s essential.

The latest in drug and technology developments and updates from July 2025.

Paul Levine, OD, FAAO, FIAOMC, details a pediatric case of high myopia in which the patient's prescription had increased from –5.75 DS OU to OD –7.00 DS, OS –6.75 DS within a year.

The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

Joe Shovlin, OD, FAAO, sat down with Optometry Times to detail a presentation he gave at AOA's Optometry's Meeting 2025.

Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.

Laura Holtz, OD, states that although it is a small part of the cornea, the epithelium plays a vital role that affects refractive surgery recommendations, diagnosis of corneal ectasias, and contact lens warpage.

The surgery isn't over until the healing is don

Maxitrol has been the leading corticosteroid/antibiotic combination drop for the treatment of ocular inflammation and bacterial infections for more than 50 years.

Jamie Kuzniar, OD, FAAO, FSLS, has found her niche in specialty contact lenses and individualized care at her practice, Elevate Eye Care + Eyewear.